MedTrace Logo

The Low Voltage Guided Ablation Trial of Persistent Atrial Fibrillation

NCT02732626 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 324

Last updated 2022-03-28

No results posted yet for this study

Summary

This study evaluates if the exclusion of left atrial low voltage areas / scars by ablation lines in addition to pulmonary vein isolation may improve the outcome in patients with persistent atrial fibrillation in comparison to stand alone pulmonary vein isolation.

Conditions

  • Persistent Atrial Fibrillation

Interventions

PROCEDURE

radiofrequency ablation

Sponsors & Collaborators

  • Technische Universität Dresden

    collaborator OTHER

  • Medical University of Vienna

    collaborator OTHER

  • Medical University of Lublin

    collaborator OTHER

  • Elisabethinen Hospital

    collaborator OTHER

  • Mödling Hospital

    lead OTHER

Principal Investigators

  • Christopher Piorkowski, MD · Heart Center Dresden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Austria
  • Germany
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02732626 on ClinicalTrials.gov